The sequential decline in gross margin suggests that rising labor and merchandise costs are outpacing pricing power, a trend that may persist if cremation rates continue to climb. Operating margin, though down, remains above the 18% levels seen in early 2024, implying that SG&A discipline has partially offset revenue stagnation. However, the 2026Q2 net margin of 11.9% is below the 19.5% peak in 2025Q1, reflecting both operational deleverage and non-operating volatility.

The persistently low ROIC, despite a stable asset turnover of 0.08, indicates that margins are insufficient to generate attractive returns on the company's large asset base, which is heavily weighted by goodwill from acquisitions. ROE improved from 3.4% in 2024Q2 to 4.5% in 2026Q2, but this remains modest and is partly driven by financial leverage rather than operational efficiency. The gap between ROE and ROIC highlights the impact of debt, but the overall trend suggests that the roll-up strategy is not yet translating into superior capital efficiency.

The increase in DSO suggests that customers are taking longer to pay, which could strain liquidity if the trend continues, especially given the thin cash balance. DIO remained stable at 10 days, while DPO improved to 19 days from 17 days, but the net effect is a modest drag on cash flow. This lengthening cycle, combined with negative working capital changes in most quarters, implies that CSV is not efficiently converting its sales into cash, a concern given its high debt load.

The reduction in D/E is a positive sign, but total debt of $549.3M remains substantial relative to equity of $279.4M, and the D/EBITDA ratio of 30.06 in 2026Q2 is alarmingly high, though this may be distorted by low EBITDA in the quarter. Interest coverage of 3.54 provides some comfort, but it is below the 4.60 seen in 2025Q1, suggesting that debt service is becoming less comfortable as volumes decline. The company's ability to refinance or maintain its acquisition pipeline could be constrained if interest rates remain elevated.

The improvement in liquidity ratios suggests better short-term coverage, but the absolute cash position is precarious, leaving little room for unexpected cash needs. The quick ratio of 1.29 indicates that receivables and other liquid assets can cover current liabilities, but this relies on the collectability of receivables, which is uncertain given rising DSO. Under a severe stress scenario, such as a prolonged mortality decline, the thin cash buffer could force the company to draw on credit lines or curtail acquisitions.

The valuation gap likely reflects CSV's smaller scale, higher leverage, and sensitivity to local market fluctuations, as well as its recent EPS miss. However, CSV's PEG of 0.43 versus SCI's 3.94 implies that the market expects much lower growth from SCI, or that CSV is undervalued relative to its growth prospects. The discount may also be warranted given CSV's lower ROE (4.5% vs 39.7%) and ROIC (2.2% vs 11.3%), indicating that SCI generates superior returns on capital. Investors should monitor whether CSV can close this gap through operational improvements or if the discount is structural.